Rocket Pharmaceuticals Inc (RCKT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.53
• Market Cap: $468.60M
• EPS: $-2.25
• 52-Week High: $9.73
• 52-Week Low: $2.19

Market Sentiment

Rocket Pharmaceuticals Inc currently has a Neutral sentiment score of 0.03.

About Rocket Pharmaceuticals Inc

Rocket Pharmaceuticals, Inc. is a pioneering biotechnology firm headquartered in Cranbury, New Jersey, specialized in developing innovative gene therapies for rare and life-threatening pediatric disorders. With its proprietary platform technologies, Rocket is committed to addressing substantial unmet medical needs through transformative therapeutic solutions. The company's extensive pipeline reflects its dedication to enhancing patient outcomes and revolutionizing the treatment landscape for ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Rocket Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does RCKT pay dividends?

Rocket Pharmaceuticals Inc (RCKT) does not currently pay a regular dividend.

What is RCKT's market cap?

Rocket Pharmaceuticals Inc (RCKT) has a market capitalization of $468.60M with a current stock price of $4.53.